Weight
Tirzepatide
Dual GIP and GLP-1 receptor agonist studied for insulin regulation and metabolic balance.
Research Use Only: NuveraPeptides products are intended for laboratory and scientific research purposes only.
Purchase option
Tirzepatide is a novel dual agonist that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously. This dual mechanism provides a unique research model for studying how combined incretin signaling affects insulin secretion, glucagon suppression, and energy utilization. Each vial contains 10mg of lyophilized tirzepatide at ≥99% purity.
What it does
- Dual GIP + GLP-1 receptor agonist
- 10mg lyophilized powder — ≥99% purity verified
- Unique tool for incretin signaling research
- Third-party tested by independent ISO-certified lab
- Cold-chain shipped with Certificate of Analysis
How to use
Reconstitute with 1–2mL bacteriostatic water. Gently swirl until fully dissolved.
Store lyophilized at 2–8°C. Once reconstituted, refrigerate and use within 30 days.
For research use only.
What’s in the box
- 1 lyophilized vial
- Certificate of Analysis
- Desiccant pack
Product FAQ
Semaglutide is a single GLP-1 agonist; tirzepatide activates both GIP and GLP-1 receptors. This dual action makes it a distinct research tool for studying combined incretin pathway effects.
≥99% purity, verified by independent HPLC and mass spectrometry. Certificate of Analysis provided with every shipment.
Combination research is at the discretion of the researcher. Consult relevant literature before combining research compounds.